Search for: "KING DRUG CO OF FLORENCE INC"
Results 1 - 15
of 15
Sorted by Relevance
|
Sort by Date
30 Jun 2015, 9:59 pm
It was evident that the presence of a large cash payment from the innovator (branded) drug company to the generic challenger as part of a "reverse payment" settlement agreement in ANDA litigation was enough to provoke a "rule of reason" antitrust analysis according to the rubrics set forth in Justice Breyer's opinion. [read post]
11 Nov 2011, 2:00 am
In King Drug Co. of Florence, Inc. v. [read post]
5 Apr 2016, 2:12 am
At the petition stage, briefs have also been filed by the Generic Pharmaceutical Association PhRMA, WLF, and the Nat’l Assn of Manufacturers. = = = = = [1] King Drug Co. of Florence, Inc. v. [read post]
25 Apr 2010, 5:52 pm
The FTC’s Annual Report focuses on three cases the Commission has been involved in concerning patent settlement agreements: King Drug Co. of Florence, Inc. v. [read post]
22 Feb 2012, 10:21 am
King Drug Co. of Florence, Inc. v. [read post]
18 Sep 2016, 6:03 pm
King Drug Company of Florence, Inc., et al., No. 15-1055 (antitrust reverse payment – appeal from the 3rd Cir.) 3. [read post]
16 Jan 2017, 5:44 pm
King Drug Company of Florence, Inc., et al., No. 15-1055 (antitrust reverse payment – appeal from the 3rd Cir.) [read post]
28 Sep 2016, 8:39 am
King Drug Company of Florence, Inc., et al., No. 15-1055 (antitrust reverse payment – appeal from the 3rd Cir.) 3. [read post]
8 Feb 2017, 3:09 am
King Drug Company of Florence, Inc., et al., No. 15-1055 (antitrust reverse payment – appeal from the 3rd Cir.) [read post]
5 Sep 2016, 6:46 pm
King Drug Company of Florence, Inc., et al., No. 15-1055 (antitrust reverse payment – appeal from the 3rd Cir.) 3. [read post]
14 Nov 2016, 9:16 am
King Drug Company of Florence, Inc., et al., No. 15-1055 (antitrust reverse payment – appeal from the 3rd Cir.) 3. [read post]
13 Oct 2016, 6:50 am
King Drug Company of Florence, Inc., et al., No. 15-1055 (antitrust reverse payment – appeal from the 3rd Cir.) 3. [read post]
15 Oct 2021, 9:43 am
Court of Appeals for the 3rd Circuit held in King Drug Co. of Florence v. [read post]
17 Oct 2018, 4:19 pm
The experience of Anthem, Inc. illustrates this point. [read post]
16 Oct 2018, 3:55 pm
Health plans, their employer and other sponsors and fiduciaries, health insurers, health care providers, health care clearinghouses and their business associates should study and learn from the just announced, record-setting $16 million resolution agreement between health insurance giant, Anthem, Inc., to resolve Department of Health & Human Services Office of Civil Rights (OCR) charges that Anthem, Inc. [read post]
